Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

PHASE2CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

April 5, 2010

Primary Completion Date

July 18, 2010

Study Completion Date

July 18, 2010

Conditions

Sleep Deprivation

Interventions

DRUG

SPD489 20 mg

Single oral dose of 20 mg

DRUG

SPD489 50 mg

Single oral dose of 50 mg

DRUG

SPD489 70 mg

Single oral dose of 70 mg

DRUG

Armodafinil

Single oral dose of 250 mg

DRUG

Placebo

Single oral dose

Trial Locations (1)

Clinilabs, Inc., New York